83 related articles for article (PubMed ID: 10223463)
1. The hPMS2 exon 5 mutation and malignant glioma. Case report.
Taylor MD; Perry J; Zlatescu MC; Stemmer-Rachamimov AO; Ang LC; Ino Y; Schwartz M; Becker LE; Louis DN; Cairncross JG
J Neurosurg; 1999 May; 90(5):946-50. PubMed ID: 10223463
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.
De Rosa M; Fasano C; Panariello L; Scarano MI; Belli G; Iannelli A; Ciciliano F; Izzo P
Oncogene; 2000 Mar; 19(13):1719-23. PubMed ID: 10763829
[TBL] [Abstract][Full Text] [Related]
4. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of Turcot's syndrome.
Hamilton SR; Liu B; Parsons RE; Papadopoulos N; Jen J; Powell SM; Krush AJ; Berk T; Cohen Z; Tetu B
N Engl J Med; 1995 Mar; 332(13):839-47. PubMed ID: 7661930
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.
Senba S; Konishi F; Okamoto T; Kashiwagi H; Kanazawa K; Miyaki M; Konishi M; Tsukamoto T
Cancer; 1998 Jan; 82(2):279-85. PubMed ID: 9445183
[TBL] [Abstract][Full Text] [Related]
7. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.
Franco-Hernández C; Martínez-Glez V; de Campos JM; Isla A; Vaquero J; Gutiérrez M; Casartelli C; Rey JA
Cancer Genet Cytogenet; 2009 Apr; 190(2):93-6. PubMed ID: 19380026
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
[TBL] [Abstract][Full Text] [Related]
9. Single gene complementation of the hPMS2 defect in HEC-1-A endometrial carcinoma cells.
Risinger JI; Umar A; Glaab WE; Tindall KR; Kunkel TA; Barrett JC
Cancer Res; 1998 Jul; 58(14):2978-81. PubMed ID: 9679958
[TBL] [Abstract][Full Text] [Related]
10. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
[TBL] [Abstract][Full Text] [Related]
12. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
13. Hypothesis: Possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects.
Gottschling S; Reinhard H; Pagenstecher C; Krüger S; Raedle J; Plotz G; Henn W; Buettner R; Meyer S; Graf N
Eur J Pediatr; 2008 Feb; 167(2):225-9. PubMed ID: 17387511
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors.
Pang JC; Dong Z; Zhang R; Liu Y; Zhou LF; Chan BW; Poon WS; Ng HK
Int J Cancer; 2003 May; 105(1):76-81. PubMed ID: 12672033
[TBL] [Abstract][Full Text] [Related]
15. [Genetics and brain gliomas].
Alentorn A; Labussière M; Sanson M; Delattre JY; Hoang-Xuan K; Idbaih A
Presse Med; 2013 May; 42(5):806-13. PubMed ID: 22789312
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
[TBL] [Abstract][Full Text] [Related]
17. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas.
Sahm F; Koelsche C; Meyer J; Pusch S; Lindenberg K; Mueller W; Herold-Mende C; von Deimling A; Hartmann C
Acta Neuropathol; 2012 Jun; 123(6):853-60. PubMed ID: 22588899
[TBL] [Abstract][Full Text] [Related]
18. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors.
Mori T; Nagase H; Horii A; Miyoshi Y; Shimano T; Nakatsuru S; Aoki T; Arakawa H; Yanagisawa A; Ushio Y
Genes Chromosomes Cancer; 1994 Mar; 9(3):168-72. PubMed ID: 7515658
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability.
Basil JB; Swisher EM; Herzog TJ; Rader JS; Elbendary A; Mutch DG; Goodfellow PJ
Gynecol Oncol; 1999 Sep; 74(3):395-9. PubMed ID: 10479499
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization of the human PMS2 gene family.
Nicolaides NC; Carter KC; Shell BK; Papadopoulos N; Vogelstein B; Kinzler KW
Genomics; 1995 Nov; 30(2):195-206. PubMed ID: 8586419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
